APO Research
Talk to an analyst

APO RESEARCH · REPORT

Immunomodulators

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Immunomodulators Industry Growth and Trends Forecast to 2032

22 December 202596 pages

Choose your research edition.

Industry ResearchImmunomodulators Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Immunomodulators Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Immunomodulators Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immunomodulators Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Immunomodulators Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Immunomodulators market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Immunomodulators is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Immunomodulators is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Immunomodulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Immunomodulators include Abbott, Johnson & Johnson, Novartis AG, Merck & Co. Inc., Roche, Eli Lilly and Company, Biogen, Amgen Inc. and Bristol-Myers Squibb Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Immunomodulators market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Immunomodulators market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Immunomodulators market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Immunomodulators.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Immunomodulators market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Immunomodulators Market by Company

Abbott

Johnson & Johnson

Novartis AG

Merck & Co. Inc.

Roche

Eli Lilly and Company

Biogen

Amgen Inc.

Bristol-Myers Squibb Company

Immunomodulators Segment by Type

Immunosuppressant

Immunostimulants

Immunomodulators Segment by Application

HIV

Respiratory

Oncology

Others

Immunomodulators Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunomodulators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immunomodulators and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunomodulators.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Immunomodulators manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Immunomodulators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Immunosuppressant Table 2. Major Company of Immunostimulants Table 3. Global Immunomodulators Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Immunomodulators Sales by Type (2021-2026) & (k units) Table 5. Global Immunomodulators Sales Market Share in Volume by Type (2021-2026) Table 6. Global Immunomodulators Sales by Type (2021-2026) & (US$ Million) Table 7. Global Immunomodulators Sales Market Share in Value by Type (2021-2026) Table 8. Global Immunomodulators Price by Type (2021-2026) & (US$/unit) Table 9. Global Immunomodulators Sales by Type (2027-2032) & (k units) Table 10. Global Immunomodulators Sales Market Share in Volume by Type (2027-2032) Table 11. Global Immunomodulators Sales by Type (2027-2032) & (US$ Million) Table 12. Global Immunomodulators Sales Market Share in Value by Type (2027-2032) Table 13. Global Immunomodulators Price by Type (2027-2032) & (US$/unit) Table 14. North America Immunomodulators Sales by Type (2021-2026) & (k units) Table 15. North America Immunomodulators Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Immunomodulators Sales by Type (2021-2026) & (k units) Table 17. Europe Immunomodulators Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Immunomodulators Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Immunomodulators Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Immunomodulators Sales by Type (2021-2026) & (k units) Table 21. Latin America Immunomodulators Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Immunomodulators Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Immunomodulators Sales by Type (2021-2026) & (US$ Million) Table 24. Immunomodulators Industry Trends Table 25. Immunomodulators Industry Drivers Table 26. Immunomodulators Industry Opportunities and Challenges Table 27. Immunomodulators Industry Restraints Table 28. Global Immunomodulators Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Immunomodulators Revenue Market Share by Company (2021-2026) Table 30. Global Immunomodulators Sales by Company (2021-2026) & (k units) Table 31. Global Immunomodulators Sales Share by Company (2021-2026) Table 32. Global Immunomodulators Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Immunomodulators Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Immunomodulators Major Company Production Sites and Headquarters Table 35. Global Immunomodulators Company, Product Type & Application Table 36. Global Immunomodulators Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Immunomodulators by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Immunomodulators Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Immunomodulators Sales by Region (2021-2026) & (k units) Table 41. Global Immunomodulators Sales Market Share in Volume by Region (2021-2026) Table 42. Global Immunomodulators Sales by Region (2021-2026) & (US$ Million) Table 43. Global Immunomodulators Sales Market Share in Value by Region (2021-2026) Table 44. Global Immunomodulators Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Immunomodulators Sales by Region (2027-2032) & (k units) Table 46. Global Immunomodulators Sales Market Share in Volume by Region (2027-2032) Table 47. Global Immunomodulators Sales by Region (2027-2032) & (US$ Million) Table 48. Global Immunomodulators Sales Market Share in Value by Region (2027-2032) Table 49. Global Immunomodulators Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Immunomodulators Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Immunomodulators Sales by Application (2021-2026) & (k units) Table 52. Global Immunomodulators Sales Market Share in Volume by Application (2021-2026) Table 53. Global Immunomodulators Sales by Application (2021-2026) & (US$ Million) Table 54. Global Immunomodulators Sales Market Share in Value by Application (2021-2026) Table 55. Global Immunomodulators Price by Application (2021-2026) & (US$/unit) Table 56. Global Immunomodulators Sales by Application (2027-2032) & (k units) Table 57. Global Immunomodulators Sales Market Share in Volume by Application (2027-2032) Table 58. Global Immunomodulators Sales by Application (2027-2032) & (US$ Million) Table 59. Global Immunomodulators Sales Market Share in Value by Application (2027-2032) Table 60. Global Immunomodulators Price by Application (2027-2032) & (US$/unit) Table 61. North America Immunomodulators Sales by Application (2021-2026) & (k units) Table 62. North America Immunomodulators Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Immunomodulators Sales by Application (2021-2026) & (k units) Table 64. Europe Immunomodulators Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Immunomodulators Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Immunomodulators Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Immunomodulators Sales by Application (2021-2026) & (k units) Table 68. Latin America Immunomodulators Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Immunomodulators Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Immunomodulators Sales by Application (2021-2026) & (US$ Million) Table 71. Abbott Company Information Table 72. Abbott Business Overview Table 73. Abbott Immunomodulators Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Abbott Immunomodulators Product Portfolio Table 75. Abbott Recent Development Table 76. Johnson & Johnson Company Information Table 77. Johnson & Johnson Business Overview Table 78. Johnson & Johnson Immunomodulators Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Johnson & Johnson Immunomodulators Product Portfolio Table 80. Johnson & Johnson Recent Development Table 81. Novartis AG Company Information Table 82. Novartis AG Business Overview Table 83. Novartis AG Immunomodulators Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Novartis AG Immunomodulators Product Portfolio Table 85. Novartis AG Recent Development Table 86. Merck & Co. Inc. Company Information Table 87. Merck & Co. Inc. Business Overview Table 88. Merck & Co. Inc. Immunomodulators Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Merck & Co. Inc. Immunomodulators Product Portfolio Table 90. Merck & Co. Inc. Recent Development Table 91. Roche Company Information Table 92. Roche Business Overview Table 93. Roche Immunomodulators Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Roche Immunomodulators Product Portfolio Table 95. Roche Recent Development Table 96. Eli Lilly and Company Company Information Table 97. Eli Lilly and Company Business Overview Table 98. Eli Lilly and Company Immunomodulators Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Eli Lilly and Company Immunomodulators Product Portfolio Table 100. Eli Lilly and Company Recent Development Table 101. Biogen Company Information Table 102. Biogen Business Overview Table 103. Biogen Immunomodulators Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Biogen Immunomodulators Product Portfolio Table 105. Biogen Recent Development Table 106. Amgen Inc. Company Information Table 107. Amgen Inc. Business Overview Table 108. Amgen Inc. Immunomodulators Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Amgen Inc. Immunomodulators Product Portfolio Table 110. Amgen Inc. Recent Development Table 111. Bristol-Myers Squibb Company Company Information Table 112. Bristol-Myers Squibb Company Business Overview Table 113. Bristol-Myers Squibb Company Immunomodulators Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Bristol-Myers Squibb Company Immunomodulators Product Portfolio Table 115. Bristol-Myers Squibb Company Recent Development Table 116. North America Immunomodulators Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. North America Immunomodulators Sales by Country (2021-2026) & (k units) Table 118. North America Immunomodulators Sales Market Share by Country (2021-2026) Table 119. North America Immunomodulators Sales Forecast by Country (2027-2032) & (k units) Table 120. North America Immunomodulators Sales Market Share Forecast by Country (2027-2032) Table 121. North America Immunomodulators Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Immunomodulators Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Immunomodulators Market Share by Country (2021-2026) Table 124. North America Immunomodulators Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Immunomodulators Market Share Forecast by Country (2027-2032) Table 126. Europe Immunomodulators Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Europe Immunomodulators Sales by Country (2021-2026) & (k units) Table 128. Europe Immunomodulators Sales Market Share by Country (2021-2026) Table 129. Europe Immunomodulators Sales Forecast by Country (2027-2032) & (k units) Table 130. Europe Immunomodulators Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Immunomodulators Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Immunomodulators Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Immunomodulators Market Share by Country (2021-2026) Table 134. Europe Immunomodulators Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Immunomodulators Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Immunomodulators Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Immunomodulators Sales by Country (2021-2026) & (k units) Table 138. Asia-Pacific Immunomodulators Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Immunomodulators Sales Forecast by Country (2027-2032) & (k units) Table 140. Asia-Pacific Immunomodulators Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Immunomodulators Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Immunomodulators Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Immunomodulators Market Share by Country (2021-2026) Table 144. Asia-Pacific Immunomodulators Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Immunomodulators Market Share Forecast by Country (2027-2032) Table 146. Latin America Immunomodulators Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Latin America Immunomodulators Sales by Country (2021-2026) & (k units) Table 148. Latin America Immunomodulators Sales Market Share by Country (2021-2026) Table 149. Latin America Immunomodulators Sales Forecast by Country (2027-2032) & (k units) Table 150. Latin America Immunomodulators Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Immunomodulators Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Immunomodulators Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Immunomodulators Market Share by Country (2021-2026) Table 154. Latin America Immunomodulators Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Immunomodulators Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Immunomodulators Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Immunomodulators Sales by Country (2021-2026) & (k units) Table 158. Middle East and Africa Immunomodulators Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Immunomodulators Sales Forecast by Country (2027-2032) & (k units) Table 160. Middle East and Africa Immunomodulators Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Immunomodulators Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Immunomodulators Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Immunomodulators Market Share by Country (2021-2026) Table 164. Middle East and Africa Immunomodulators Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Immunomodulators Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Immunomodulators Distributors List Table 169. Immunomodulators Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Immunomodulators Image Figure 2. Global Immunomodulators Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immunomodulators Market Size (2021-2032) & (US$ Million) Figure 4. Global Immunomodulators Sales (2021-2032) & (k units) Figure 5. Immunosuppressant Image Figure 6. Global Immunosuppressant Sales YoY Growth (2021-2032) & (k units) Figure 7. Immunostimulants Image Figure 8. Global Immunostimulants Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Immunomodulators Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Immunomodulators Market Share by Type 2025 VS 2032 Figure 11. North America Immunomodulators Sales Market Share in Volume by Type in 2025 Figure 12. North America Immunomodulators Sales Market Share in Value by Type in 2025 Figure 13. Europe Immunomodulators Sales Market Share in Volume by Type in 2025 Figure 14. Europe Immunomodulators Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Immunomodulators Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Immunomodulators Sales Market Share in Value by Type in 2025 Figure 17. Latin America Immunomodulators Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Immunomodulators Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Immunomodulators Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Immunomodulators Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Immunomodulators Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. HIV Image Figure 24. Global HIV Sales YoY Growth (2021-2032) & (k units) Figure 25. Respiratory Image Figure 26. Global Respiratory Sales YoY Growth (2021-2032) & (k units) Figure 27. Oncology Image Figure 28. Global Oncology Sales YoY Growth (2021-2032) & (k units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Immunomodulators Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Immunomodulators Market Share by Application 2025 VS 2032 Figure 33. North America Immunomodulators Sales Market Share in Volume by Application in 2025 Figure 34. North America Immunomodulators Sales Market Share in Value by Application in 2025 Figure 35. Europe Immunomodulators Sales Market Share in Volume by Application in 2025 Figure 36. Europe Immunomodulators Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Immunomodulators Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Immunomodulators Sales Market Share in Value by Application in 2025 Figure 39. Latin America Immunomodulators Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Immunomodulators Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Immunomodulators Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Immunomodulators Sales Market Share in Value by Application in 2025 Figure 43. North America Immunomodulators Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Immunomodulators Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Immunomodulators Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Immunomodulators Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Immunomodulators Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Immunomodulators Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Immunomodulators Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Immunomodulators Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Immunomodulators Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Immunomodulators Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Immunomodulators Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Immunomodulators Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Immunomodulators Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Immunomodulators Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Immunomodulators Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Immunomodulators Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Immunomodulators Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Immunomodulators Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Immunomodulators Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Immunomodulators Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Immunomodulators Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Immunomodulators Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Immunosuppressant
  • Immunostimulants
Applications
  • HIV
  • Respiratory
  • Oncology
  • Others
Companies covered
  • Abbott
  • Johnson & Johnson
  • Novartis AG
  • Merck & Co. Inc.
  • Roche
  • Eli Lilly and Company
  • Biogen
  • Amgen Inc.
  • Bristol-Myers Squibb Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Immunomodulators Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Immunomodulators Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Immunomodulators Market by Type
  6. 1.3.1 Immunosuppressant
  7. 1.3.2 Immunostimulants
  8. 1.4 Global Immunomodulators Market Size by Type
  9. 1.4.1 Global Immunomodulators Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Immunomodulators Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Immunomodulators Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Immunomodulators Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Immunomodulators Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Immunomodulators Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Immunomodulators Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Immunomodulators Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Immunomodulators Industry Trends
  2. 2.2 Immunomodulators Industry Drivers
  3. 2.3 Immunomodulators Industry Opportunities and Challenges
  4. 2.4 Immunomodulators Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Immunomodulators Revenue (2021-2026)
  2. 3.2 Global Top Players by Immunomodulators Sales (2021-2026)
  3. 3.3 Global Top Players by Immunomodulators Price (2021-2026)
  4. 3.4 Global Immunomodulators Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Immunomodulators Major Company Production Sites & Headquarters
  6. 3.6 Global Immunomodulators Company, Product Type & Application
  7. 3.7 Global Immunomodulators Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Immunomodulators Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Immunomodulators Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Immunomodulators Tier 1, Tier 2, and Tier 3
4 Immunomodulators Regional Status and Outlook
  1. 4.1 Global Immunomodulators Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Immunomodulators Historic Market Size by Region
  3. 4.2.1 Global Immunomodulators Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Immunomodulators Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Immunomodulators Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Immunomodulators Forecasted Market Size by Region
  7. 4.3.1 Global Immunomodulators Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Immunomodulators Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Immunomodulators Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Immunomodulators by Application
  1. 5.1 Immunomodulators Market by Application
  2. 5.1.1 HIV
  3. 5.1.2 Respiratory
  4. 5.1.3 Oncology
  5. 5.1.4 Others
  6. 5.2 Global Immunomodulators Market Size by Application
  7. 5.2.1 Global Immunomodulators Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Immunomodulators Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Immunomodulators Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Immunomodulators Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Immunomodulators Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Immunomodulators Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Immunomodulators Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Immunomodulators Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Immunomodulators Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Immunomodulators Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Immunomodulators Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson Immunomodulators Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Novartis AG
  14. 6.3.1 Novartis AG Company Information
  15. 6.3.2 Novartis AG Business Overview
  16. 6.3.3 Novartis AG Immunomodulators Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis AG Immunomodulators Product Portfolio
  18. 6.3.5 Novartis AG Recent Developments
  19. 6.4 Merck & Co. Inc.
  20. 6.4.1 Merck & Co. Inc. Company Information
  21. 6.4.2 Merck & Co. Inc. Business Overview
  22. 6.4.3 Merck & Co. Inc. Immunomodulators Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Merck & Co. Inc. Immunomodulators Product Portfolio
  24. 6.4.5 Merck & Co. Inc. Recent Developments
  25. 6.5 Roche
  26. 6.5.1 Roche Company Information
  27. 6.5.2 Roche Business Overview
  28. 6.5.3 Roche Immunomodulators Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Roche Immunomodulators Product Portfolio
  30. 6.5.5 Roche Recent Developments
  31. 6.6 Eli Lilly and Company
  32. 6.6.1 Eli Lilly and Company Company Information
  33. 6.6.2 Eli Lilly and Company Business Overview
  34. 6.6.3 Eli Lilly and Company Immunomodulators Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Eli Lilly and Company Immunomodulators Product Portfolio
  36. 6.6.5 Eli Lilly and Company Recent Developments
  37. 6.7 Biogen
  38. 6.7.1 Biogen Company Information
  39. 6.7.2 Biogen Business Overview
  40. 6.7.3 Biogen Immunomodulators Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Biogen Immunomodulators Product Portfolio
  42. 6.7.5 Biogen Recent Developments
  43. 6.8 Amgen Inc.
  44. 6.8.1 Amgen Inc. Company Information
  45. 6.8.2 Amgen Inc. Business Overview
  46. 6.8.3 Amgen Inc. Immunomodulators Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Amgen Inc. Immunomodulators Product Portfolio
  48. 6.8.5 Amgen Inc. Recent Developments
  49. 6.9 Bristol-Myers Squibb Company
  50. 6.9.1 Bristol-Myers Squibb Company Company Information
  51. 6.9.2 Bristol-Myers Squibb Company Business Overview
  52. 6.9.3 Bristol-Myers Squibb Company Immunomodulators Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Bristol-Myers Squibb Company Immunomodulators Product Portfolio
  54. 6.9.5 Bristol-Myers Squibb Company Recent Developments
7 North America by Country
  1. 7.1 North America Immunomodulators Sales by Country
  2. 7.1.1 North America Immunomodulators Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Immunomodulators Sales by Country (2021-2026)
  4. 7.1.3 North America Immunomodulators Sales Forecast by Country (2027-2032)
  5. 7.2 North America Immunomodulators Market Size by Country
  6. 7.2.1 North America Immunomodulators Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Immunomodulators Market Size by Country (2021-2026)
  8. 7.2.3 North America Immunomodulators Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Immunomodulators Sales by Country
  2. 8.1.1 Europe Immunomodulators Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Immunomodulators Sales by Country (2021-2026)
  4. 8.1.3 Europe Immunomodulators Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Immunomodulators Market Size by Country
  6. 8.2.1 Europe Immunomodulators Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Immunomodulators Market Size by Country (2021-2026)
  8. 8.2.3 Europe Immunomodulators Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Immunomodulators Sales by Country
  2. 9.1.1 Asia-Pacific Immunomodulators Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Immunomodulators Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Immunomodulators Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Immunomodulators Market Size by Country
  6. 9.2.1 Asia-Pacific Immunomodulators Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Immunomodulators Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Immunomodulators Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Immunomodulators Sales by Country
  2. 10.1.1 South America Immunomodulators Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Immunomodulators Sales by Country (2021-2026)
  4. 10.1.3 South America Immunomodulators Sales Forecast by Country (2027-2032)
  5. 10.2 South America Immunomodulators Market Size by Country
  6. 10.2.1 South America Immunomodulators Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Immunomodulators Market Size by Country (2021-2026)
  8. 10.2.3 South America Immunomodulators Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Immunomodulators Sales by Country
  2. 11.1.1 Middle East and Africa Immunomodulators Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Immunomodulators Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Immunomodulators Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Immunomodulators Market Size by Country
  6. 11.2.1 Middle East and Africa Immunomodulators Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Immunomodulators Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Immunomodulators Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Immunomodulators Value Chain Analysis
  2. 12.1.1 Immunomodulators Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Immunomodulators Production Mode & Process
  7. 12.2 Immunomodulators Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Immunomodulators Distributors
  10. 12.2.3 Immunomodulators Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst